In line with TGA regulatory changes to enhance medicine safety, PSA has developed a cautionary advisory label that warns consumers about the risk of opioid overdose and dependence.

A cheap and widely used corticosteroid may be employed by Australian doctors in the treatment of seriously ill COVID-19 patients.

From next Wednesday, proposed customs regulations will prohibit the importation of e-cigarettes containing vaporiser nicotine (nicotine liquids and salts) and nicotine-containing refills.

With three deaths a day involving opioid use, Thea Cowie explores what role pharmacists can play in reducing the toll and ensuring the safe use of opioids.

A digital image prescription is a digital copy of a prescription provided by the prescriber to the patient’s pharmacy following a telehealth consultation.

For more than a decade, healthcare workers in rural and remote areas have been aware of the rising incidence of non-prescribed opioid medicines use. But access to treatment there remains challenging. Australians living in these areas are significantly more likely...

Burnout, by its nature, isn’t easy to head off. Spotting the warning signs early gives the best chance of dealing with it.

At the peak of the COVID-19 pandemic, many pharmacists were faced with questions about treatment for which they felt they had no evidence-based answers.

The long-awaited Seventh Community Pharmacy Agreement was signed last Thursday, providing Australians with better access to pharmacists and supporting the safe and quality use of medicines.

Three pharmacists were recognised in this year’s Queen’s Birthday Honours List, highlighting the varied and important roles pharmacists play in their communities.